Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
EMBO Molecular Medicine|September 8, 2018
Selective depletion of metastatic stem cells as therapy for human colorectal cancerMaría Virtudes Céspedes, Ugutz Unzueta, Anna Aviñó, et al.Pharmacological Research|October 13, 2025
Nanotoxin induces in situ pyroptosis to sensitize αPD1 to ablate metastases in microsattellite stable colorectal cancerLuis M Carrasco-Díaz, Marc Otero-Mateo, Patricia Álamo, et al.Pharmaceutics|April 23, 2022
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse ModelElisa Rioja-Blanco, Alberto Gallardo, Irene Arroyo-Solera, et al.Cancers|July 2, 2021
Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4<sup>+</sup> CancersOlivia Cano-Garrido, Patricia Álamo, Laura Sánchez-García, et al.Journal of Experimental & Clinical Cancer Research : CR|February 5, 2022
CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinomaElisa Rioja-Blanco, Irene Arroyo-Solera, Patricia Álamo, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 20, 2022
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug deliveryNaroa Serna, Victor Pallarès, Ugutz Unzueta, et al.Oncotarget|September 12, 2015
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patientsMiguel Angel Pavón, Irene Arroyo-Solera, Marta Téllez-Gabriel, et al.Head & Neck|October 31, 2015
CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinomaMiguel Angel Pavón, Matilde Parreño, Marta Téllez-Gabriel, et al.Plos One|June 20, 2018
CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosisMaría José Moreno, Alberto Gallardo, Silvana Novelli, et al.The Journal of Pathology|September 19, 2014
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survivalMaría José Moreno, Rosa Bosch, Rebeca Dieguez-Gonzalez, et al.Pageof 7